Multimodal gene and targeted drug therapy for chronic myelogenous leukemia: Computational target analysis and therapeutic validationMargaret L. Lugin(University of California, Irvine), Young Jik Kwon(University of California, Irvine)bioRxiv (Cold Spring Harbor Laboratory)May 29, 202510.1101/2025.05.26.656072Cited by 0SaveCiteExport RISWatch citationsRelated PapersSynergistic combination of chemo‑phototherapy based on temozolomide/ICG‑loaded iron oxide nanoparticles for brain cancer treatment|Oncology Reports|2019|35Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation|Nano Convergence|2026|0